Also from this source

You just read:

Vaccinex, Inc. Announces Initiation of a Phase 1 Clinical Trial of VX15/2503 Antibody in Multiple Sclerosis Patients

News provided by

Vaccinex, Inc.

Jan 07, 2013, 09:52 EST